Community Rehabilitation Psychiatry aims to provide long-term, holistic, recovery focused care to patients with chronic mental-health conditions struggling with their social and personal functioning [3].

The South London and Maudsley High Support Rehabilitation Team serves 120 patients within the densely populated London borough of Southwark and responded to the challenges posed by Covid-19 at a team and trust level.

Generally our patients live in supported or residential placements, require higher-risk medication such as clozapine or augmented antipsychotic strategies and suffer poor physical health. Self-neglect and isolation are significant risks and a key part of our work is encouraging patients to attend primary care appointments and bringing together services in support of their recovery and inclusion.

For these reasons, Covid-19 poses a particular challenge to our cohort. Living in communal settings they are more likely to contract the virus and with multiple co-morbidities they are more likely to die if they become unwell. They require support to seek help, follow national guidelines and organise their medication and meals during isolation. For those on clozapine Covid-19 poses a diagnostic challenge with symptoms mimicking complications such as agranulocytosis and myocarditis. Routine white cell count monitoring and urgent blood counts for those unwell pose a transmission risk between staff and other patients.

Notably, we have found during the current pandemic that unwell patients or their carers would contact our service for advice ahead of 111, primary care or emergency services, perhaps reflecting the close trust they place in our team to support them through difficulty.

Anticipating the need to provide timely, evidence-based care, we devised and introduced same-day remote assessments structured around a standard operating procedure incorporating the latest primary care guidelines [2]. A doctor, often the core trainee, would assess the patient’s physical and mental health, provide self-care and isolation advice and triage if required to further primary care (GP) input or the emergency services. Our care coordinators supported the patient with shopping and medication supplies for their isolation period and swab testing. We notified Public Health England if the criteria were met for a potential outbreak in a home. Recognising the possibility for patients to deteriorate around day 10 of their illness [2], all patients were reassessed the following week.

At a trust level, South London and Maudsley guidelines were amended permitting consultant discretion when deciding whether an urgent blood count was required for those unwell on clozapine [4] and routine blood count monitoring was extended to up to 3 months for eligible patients [1]. These changes acknowledge that some patients are at no greater risk of agranulocytosis than those on other antipsychotics [5] and frequent testing risks further community transmission. By requiring these changes, we suspect COVID-19 may have prompted a permanently less intensive monitoring regime for some patients on clozapine.

Reflecting on the role of rehabilitation psychiatry, the current pandemic has shown that community services are well placed to act as first responders to cases and, surprisingly, that this is expected of them by their patients. It is fitting, perhaps, for a service aiming to provide holistic care that its scope should have expanded in this way during the pandemic. That this primary care role is often performed by core trainees suggests a place for more rigorous primary care training within their Royal College curriculum.